As CBD Goes Mainstream, Eresos Stands Out with Uncompromising Quality

Edmonton, London Oct 12, 2023 (Issuewire.com) - A recent study published in the Journal of Cannabinoid Research revealed a concerning lack of accuracy in some CBD product labelling. Researchers analysed 63 CBD products from 40 different brands sold online in the UK. This included 13 tinctures, 29 oils, 10 e-liquids, and 11 drinks.

The team of researchers tested the actual CBD levels against the advertised concentration on the label. They found that only 5 of the 63 products had CBD content within 10% of what was claimed. CBD oils showed the least deviation, but the results still highlight a level of inaccuracy across the board.

This kind of dubious labelling has the potential to erode consumer trust in the growing CBD industry. Eresos, a UK-based wellness brand rejects this approach, dedicating itself fully to product purity, potency and compliance. The UK-based company is proud to hold Novel Foods certification for its oil drops and capsule ingestibles, adhering to the EU's stringent regulations. In addition, Eresos rigorously tests every single batch of products to guarantee they meet strict guideline standards, certifying every product to ensure consumers have complete transparency about what's inside. 

"Many brands sacrifice quality as they scale up to meet demand. We take the opposite tack - investing in top-tier sourcing, testing, and production," said CEO Carl Jat. "Our customers recognise and value our obsession with their safety and satisfaction. We believe trust through transparency is essential as more people turn to CBD's natural wellness benefits."

Inspired by Theophrastus, the godfather of ancient botany, Eresos' science-backed formulas target specific wellness needs. With strong leadership and plans to list on the London Aquis Exchange this year, the company is strategically positioned to capitalise on the CBD boom, whilst uncompromising on quality and establishing trust with consumers.